AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,604,220 | +37.1% | 105,221 | -9.5% | 0.07% | +10.0% |
| Q2 2023 | $1,899,129 | +57.5% | 116,221 | +121.4% | 0.06% | +62.2% |
| Q1 2023 | $1,205,925 | -99.6% | 52,500 | +550.1% | 0.04% | +516.7% |
| Q1 2016 | $328,000,000 | -41.3% | 8,076 | -59.6% | 0.01% | -50.0% |
| Q3 2013 | $559,000,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |